Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
Details for Australian Patent Application No. 2001288451 (hide)
International Classifications
Event Publications
11 November 2004 Assignment before Grant
Pharmacopeia, Inc.; Schering Corporation The application has been assigned to Schering Corporation; Pharmacopeia Drug Discovery, Inc. 2002
24 May 2007 Application Accepted
Published as AU-B-2001288451
13 September 2007 Assignment before Grant
Schering Corporation; Pharmacopeia Drug Discovery, Inc. The application has been assigned to Schering Corporation; Pharmacopeia, Inc. 2002
20 September 2007 Standard Patent Sealed
18 October 2007 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 06 Sep 2007. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2002
6 March 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 06 Sep 2007 2002
25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser